Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies that modulate G-protein coupled receptors (GPCRs). The company uses its proprietary GEODe platform to address challenges in GPCR-targeted drug discovery. Its lead asset, TX45, is an Fc-relaxin fusion molecule targeting RXFP1 for Group 2 PH-HFpEF and Group 3 PH-ILD. Its second candidate, TX2100, is in Phase 1a clinical trials in healthy volunteers.
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076793 | EDGAR | 90K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042648 | EDGAR | 91K words |
| 2024-03-14 | 2023-12-31 | 0000950170-24-031635 | EDGAR | 114K words |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009527 | EDGAR | — |
| 2022-03-17 | 2021-12-31 | 0001564590-22-010895 | EDGAR | — |
| 2021-03-18 | 2020-12-31 | 0001564590-21-014190 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011144 | EDGAR | — |
| 2019-03-25 | 2018-12-31 | 0001193125-19-085321 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-338062 | EDGAR | 60K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269701 | EDGAR | 62K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104974 | EDGAR | 61K words |
| 2025-05-08 | 2025-03-31 | 0000950170-25-067037 | EDGAR | 59K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125304 | EDGAR | 65K words |
| 2024-08-14 | 2024-06-30 | 0001193125-24-200609 | EDGAR | 70K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057091 | EDGAR | 68K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062131 | EDGAR | 65K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041408 | EDGAR | 65K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021318 | EDGAR | 61K words |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023269 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016117 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001193125-26-338000 | EDGAR | 3K words |
| 2026-02-26 | 0001193125-26-076843 | EDGAR | 3K words |
| 2026-02-24 | 0001193125-26-066964 | EDGAR | 4K words |
| 2025-11-06 | 0001193125-25-269573 | EDGAR | 3K words |
| 2025-10-30 | 0001193125-25-256958 | EDGAR | 2K words |
| 2025-08-07 | 0001193125-25-175567 | EDGAR | 7K words |
| 2025-06-06 | 0001193125-25-137149 | EDGAR | 1K words |
| 2025-05-19 | 0001193125-25-122511 | EDGAR | 2K words |
| 2025-05-08 | 0000950170-25-066932 | EDGAR | 2K words |
| 2025-03-20 | 0000950170-25-042630 | EDGAR | 3K words |
164 total filings indexed. 134 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001681087 |
| Ticker | TECX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NY |
| Website | https://www.tectonictx.com |
| Listed | 2024-06-21 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TECX (~200 tokens, structured JSON with cryptographic provenance)